Penumbra targets 13%-14% revenue growth for 2025 with focus on thrombectomy market expansion
Q4 2024 Management View CEO Adam Elsesser highlighted revenue of $321.3 million for Q4 2024, representing a year-over-year growth of 12.9% on an adjusted basis, driven by strong performance in the U.S ...